BofA analyst Craig Siegenthaler lowered the firm’s price target on CME Group (CME) to $201 from $204 and keeps an Underperform rating on the shares. Q3 volume was soft with sequential declines in all asset classes as a result of lower market volatility and seasonality, the analyst tells investors in a post-earnings note. The firm is lowering its Q4, 2026 and 2027 EPS estimates due to modest upward revisions to taxes and expenses, the analyst noted.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group Earnings Call: Mixed Sentiments and Future Outlook
- Midday Fly By: Tesla reports mixed Q3, Trump in talks for quantum stakes
- LendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
- CME Group price target raised to $314 from $312 at Morgan Stanley
- CME Group price target lowered to $280 from $285 at UBS